S&P 500 7,722.60 ▲ 45.83 (+0.60%) DOW 52,377.57 ▲ 15.97 (+0.03%) NASDAQ 26,477.81 ▲ 308.43 (+1.18%) US Markets Closed â€ĸ 03:24 AM ET

AHG

Akso Health Group

Price Chart
Latest Quote

$1.41

+0.14 (+11.02%)
Current Price
Previous Close $1.27
Open $1.27
Day High $1.50
Day Low $1.27
Volume 11,320
Fetched: 2026-10-28T06:46:33
Stock Information
Shares Outstanding 854.04M
Total Debt $2.38M
Cash Equivalents $171K
Revenue $13.83M
Net Income $-18.67M
Sector Healthcare
Industry Medical Distribution
Market Cap $1.21B
EPS (TTM) $-0.03
Exchange NCM
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$1.21B
Sales$13.83M
Income$-18.67M
Book/sh$0.21
Cash/sh$0.00
Employees12
Financial Ratios
Quick Ratio0.17
Current Ratio21.77
Debt/Eq1.31
Returns & Margins
ROA-1.24%
ROE-9.85%
Gross Margin-0.08%
Operating Margin-37.50%
Profit Margin-134.99%
Ownership
Institutional Ownership0.03%
Insider & Institutional transactions data not available
Valuation Ratios
P/S87.33
P/B6.68
Analyst Data
Recommendationnone
Technical Indicators
SMA20$1.24
SMA50$1.00
SMA200$1.52
RSI62.22
ATR0.1424
Shares Float854.05M
Short Ratio0.07
Volatility-1.00
Rel Volume0.04
Performance History
Week+14.91%
Month+92.89%
Quarter-3.42%
6 Months-39.48%
YTD-11.88%
Year-17.11%
3 Years+48.42%
5 Years-85.17%
10 Years-96.12%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-10-27 $1.41 11,300
2026-10-26 $1.27 6,400
2026-10-23 $1.30 1,900
2026-10-22 $1.22 7,000
2026-10-21 $1.27 4,800
2026-10-20 $1.23 7,700
2026-10-19 $1.33 1,900
2026-10-16 $1.35 3,600
2026-10-15 $1.35 2,100
2026-10-14 $1.38 9,200
2026-10-13 $1.36 8,900
2026-10-12 $1.37 25,500
2026-10-09 $1.25 21,100
2026-10-08 $1.14 8,200
2026-10-07 $1.21 16,800
2026-10-06 $1.17 20,000
2026-10-05 $1.16 29,200
2026-10-02 $1.15 82,000
2026-10-01 $1.02 237,400
2026-09-30 $0.90 5,643,300
2026-09-29 $0.69 32,900
2026-09-28 $0.73 48,100
About Akso Health Group

Akso Health Group, together with its subsidiaries, operates a social e-commerce mobile platform in the People's Republic of China. It operates Xiaobai Maimai App, a social e-commerce mobile platform that offers food and beverage products, wine, cosmetic products, fashion and apparel, entertainment, housewares, home appliances, and cost-saving promotions at petrol gas stations. The company also sells medical devices, such as defibrillators and anesthesia laryngoscopes. In addition, it provides health treatment, consultancy support, and marketing promotion services, as well as trading and technological promotion services and import and export. The company was formerly known as Xiaobai Maimai Inc. and changed its name to Akso Health Group in December 2021. Akso Health Group was founded in 2014 and is headquartered in Qingdao, China.

📰 Latest News
No news articles available at the moment. Check back later for updates on AHG.
Period:
Loading...
Income Statement (Annual)
Metric 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Revenue
Reconciled Cost Of Revenue $13,843,219 $15,059,324 $2,292,206 $11,912,571
Cost Of Revenue $13,843,219 $15,059,324 $2,292,206 $11,912,571
Total Revenue $13,831,904 $14,777,798 $2,414,338 $13,181,561
Operating Revenue $13,835,063 $14,781,622 $2,416,797 $13,186,525
Expenses
Total Expenses $17,831,960 $18,700,770 $11,052,378 $27,448,414
Other Income Expense $-16,704,389 $-162,347,307 $-453,751 $1,200,364
Other Non Operating Income Expenses $-4,385 $34,099 $138,240 $57,358
Operating Expense $3,988,741 $3,641,446 $8,760,172 $15,535,843
Selling And Marketing Expense $0 $0 $168,421 $6,661
General And Administrative Expense $3,988,741 $3,641,446 $8,591,751 $15,529,182
Interest Expense - - $0 $0
Net Non Operating Interest Income Expense - - $0 $0
Interest Expense Non Operating - - $0 $0
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $-18,671,610 $-134,977,369 $-9,058,986 $-13,196,535
Normalized Income $-3,574,806 $-2,636,523 $-8,614,993 $-14,053,790
Net Income From Continuing And Discontinued Operation $-18,671,610 $-134,977,369 $-9,458,784 $-1,359,923
Total Operating Income As Reported $-20,700,332 $-166,304,352 $-8,638,040 $-14,266,853
Net Income Common Stockholders $-18,671,610 $-134,977,369 $-9,458,784 $-1,359,923
Net Income $-18,671,610 $-134,977,369 $-9,458,784 $-1,359,923
Net Income Including Noncontrolling Interests $-18,716,181 $-135,469,133 $-9,516,577 $-1,247,426
Net Income Discontinuous Operations $0 $0 $-399,798 $11,836,612
Net Income Continuous Operations $-18,716,181 $-135,469,133 $-9,116,779 $-13,084,038
Pretax Income $-20,704,445 $-166,270,279 $-9,091,791 $-13,066,489
Special Income Charges $-16,700,276 $-162,381,380 $0 $0
Operating Income $-4,000,056 $-3,922,972 $-8,638,040 $-14,266,853
Gross Profit $-11,315 $-281,526 $122,132 $1,268,990
Net Interest Income - - $0 $0
Per Share
Diluted EPS $-0.03 $-0.48 $-0.21 $-0.06
Basic EPS $-0.03 $-0.48 $-0.21 $-0.06
Other
Tax Effect Of Unusual Items $-1,603,200 $-30,040,560 $-147,998 $285,752
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $15,071,563 $160,608,224 $-8,046,049 $-15,409,859
Total Unusual Items $-16,700,004 $-162,381,406 $-591,991 $1,143,006
Total Unusual Items Excluding Goodwill $-16,700,004 $-162,381,406 $-591,991 $1,143,006
Reconciled Depreciation $2,371,615 $2,149,790 $0 $0
EBITDA (Bullshit earnings) $-1,628,441 $-1,773,182 $-8,638,040 $-14,266,853
EBIT $-4,000,056 $-3,922,972 $-8,638,040 $-14,266,853
Diluted Average Shares $722,707,254 $285,096,112 $47,172,259 $22,866,017
Basic Average Shares $722,707,254 $285,096,112 $47,172,259 $22,866,017
Diluted NI Availto Com Stockholders $-18,671,610 $-134,977,369 $-9,458,784 $-1,359,923
Minority Interests $44,571 $491,764 $57,793 $-112,497
Tax Provision $-1,988,264 $-30,801,146 $24,988 $17,549
Impairment Of Capital Assets $16,700,276 $162,381,380 $0 $0
Gain On Sale Of Security $272 $-26 $-591,991 $1,143,006
Selling General And Administration $3,988,741 $3,641,446 $8,760,172 $15,535,843
Other Gand A $3,988,741 $3,641,446 $8,591,751 $15,529,182
Excise Taxes $3,159 $3,824 $2,459 $4,964
Salaries And Wages - - $0 $0
Write Off - - - -
Research And Development - - - -
Fetched: 2026-10-27
Balance Sheet (Annual)
Metric 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Assets
Net Tangible Assets $180,876,293 $180,405,256 $138,367,384 $8,725,304
Total Assets $189,633,385 $214,953,325 $142,018,117 $20,460,299
Total Non Current Assets $87,231 $18,828,433 $0 $0
Goodwill And Other Intangible Assets $58,319 $18,713,889 $0 -
Other Intangible Assets $58,319 $7,880,154 - -
Current Assets $189,546,154 $196,124,892 $142,018,117 $20,460,299
Other Current Assets $12,229,837 $6,809,198 $402,899 $272,129
Prepaid Assets $175,664,545 $0 $56,250,000 $0
Inventory $200,135 $190,242 $191,201 $1,686,449
Receivables $1,281,065 $12,895,578 $0 $9,225,901
Loans Receivable $0 $11,941,378 $0 -
Accounts Receivable $1,281,065 $954,200 $0 $7,696,983
Allowance For Doubtful Accounts Receivable $-7,779,173 $-7,670,556 $-7,770,556 $-400,759
Gross Accounts Receivable $9,060,238 $8,624,756 $7,770,556 $8,097,742
Cash Cash Equivalents And Short Term Investments $170,572 $176,229,874 $85,174,017 $7,924,468
Cash And Cash Equivalents $170,572 $176,229,874 $85,174,017 $7,924,468
Assets Held For Sale Current - - $0 $1,351,352
Other Non Current Assets - - - $272,129
Other Receivables - - - $1,528,918
Accrued Interest Receivable - - - -
Non Current Note Receivables - - - -
Non Current Accounts Receivable - - - -
Debt
Net Debt $179,955 - - -
Total Debt $375,659 $81,737 $0 -
Long Term Debt And Capital Lease Obligation $2,565 $41,679 $0 -
Current Debt And Capital Lease Obligation $373,094 $40,058 - -
Current Debt $350,527 - - -
Other Current Borrowings $350,527 - - -
Liabilities
Total Liabilities Net Minority Interest $8,711,006 $15,802,189 $3,593,923 $11,620,783
Total Non Current Liabilities Net Minority Interest $2,565 $1,989,282 $0 $0
Non Current Deferred Liabilities $0 $1,947,603 $0 -
Non Current Deferred Taxes Liabilities $0 $1,947,603 $0 -
Current Liabilities $8,708,441 $13,812,907 $3,593,923 $11,620,783
Current Deferred Liabilities $4,407,134 $10,217,048 $415,020 $194,376
Payables And Accrued Expenses $3,928,213 $3,555,801 $3,178,903 $10,720,924
Payables $2,093,284 $2,033,863 $2,074,091 $9,782,157
Total Tax Payable $93,284 $33,863 $74,091 $96,005
Income Tax Payable $92,816 $92,816 $92,816 $95,888
Interest Payable - $0 $9,450 $105,085
Other Current Liabilities - - - $705,483
Current Notes Payable - - - -
Equity
Common Stock Equity $180,934,612 $199,119,145 $138,367,384 $8,725,304
Total Equity Gross Minority Interest $180,922,379 $199,151,136 $138,424,194 $8,839,516
Stockholders Equity $180,934,612 $199,119,145 $138,367,384 $8,725,304
Gains Losses Not Affecting Retained Earnings $-3,284,297 $-3,771,374 $-4,086,587 $-3,847,601
Other Equity Adjustments $-3,284,297 $-3,771,374 $-4,086,587 $-3,847,601
Retained Earnings $-217,575,362 $-198,903,752 $-63,926,383 $-54,467,600
Other
Ordinary Shares Number $2,570,112,530 $1,647,602,730 $437,170,960 $68,598,050
Share Issued $2,570,112,530 $1,648,768,613 $438,336,843 $69,763,933
Tangible Book Value $180,876,293 $180,405,256 $138,367,384 $8,725,304
Invested Capital $181,285,139 $199,119,145 $138,367,384 $8,725,304
Working Capital $180,837,713 $182,311,985 $138,424,194 $8,839,516
Capital Lease Obligations $25,132 $81,737 $0 -
Total Capitalization $180,934,612 $199,119,145 $138,367,384 $8,725,304
Minority Interest $-12,233 $31,991 $56,810 $114,212
Treasury Stock $3,988,370 $3,988,370 $3,988,370 $3,988,370
Additional Paid In Capital $405,525,513 $405,616,966 $210,324,890 $71,021,898
Capital Stock $257,128 $165,675 $43,834 $6,977
Common Stock $257,128 $165,675 $43,834 $6,977
Long Term Capital Lease Obligation $2,565 $41,679 $0 -
Current Deferred Revenue $4,407,134 $10,217,048 $415,020 $194,376
Current Capital Lease Obligation $22,567 $40,058 $0 -
Current Accrued Expenses $1,834,929 $1,521,938 $1,104,812 $938,767
Dueto Related Parties Current $2,000,000 $2,000,000 $2,000,000 $9,686,152
Goodwill $0 $10,833,735 $0 -
Net PPE $28,912 $114,544 $0 -
Accumulated Depreciation $-8,354 $-1,612 - -
Gross PPE $37,266 $116,156 $0 -
Other Properties $16,897 $98,396 - -
Machinery Furniture Equipment $20,369 $17,760 - -
Finished Goods $200,135 $190,242 $191,201 $1,686,449
Treasury Shares Number - $1,165,883 $1,165,883 $1,165,883
Investments And Advances - - - -
Fetched: 2026-10-27
Cash Flow Statement (Annual)
Metric 2026-03-31 2025-03-31 2024-03-31 2023-03-31
Free Cash Flow
Free Cash Flow $-188,457,483 $1,022,703 $1,351,240 $-3,253,340
Operating Activities
Operating Cash Flow $-12,791,300 $1,177,163 $1,351,240 $-3,253,340
Cash From Discontinued Operating Activities $0 $0 $645,869 $2,729,242
Cash Flow From Continuing Operating Activities $-12,791,300 $1,177,163 $705,371 $-5,982,582
Operating Gains Losses - - - -
Investing Activities
Capital Expenditure $-175,666,183 $-154,460 - -
Investing Cash Flow $-163,464,519 $-105,912,692 $-54,721,082 $18,471,082
Cash From Discontinued Investing Activities $0 $0 $0 $0
Cash Flow From Continuing Investing Activities $-163,464,519 $-105,912,692 $-54,721,082 $18,471,082
Net Other Investing Changes $12,201,664 $-12,008,232 $1,528,918 $18,471,082
Financing Activities
Issuance Of Capital Stock $0 $195,884,024 $139,339,849 $0
Financing Cash Flow $350,000 $195,884,024 $131,653,697 $-27,513,848
Cash From Discontinued Financing Activities $0 $0 $0 $0
Cash Flow From Continuing Financing Activities $350,000 $195,884,024 $131,653,697 $-27,513,848
Net Common Stock Issuance $0 $195,884,024 $139,339,849 $0
Common Stock Issuance $0 $195,884,024 $139,339,849 $0
Repurchase Of Capital Stock - - - -
Net Other Financing Charges - - - -
Cash Dividends Paid - - - -
Other
Repayment Of Debt $0 $0 $-7,686,152 $-27,513,848
Issuance Of Debt $350,000 $0 $0 -
Interest Paid Supplemental Data $0 $0 $111,563 $336,593
Income Tax Paid Supplemental Data $1,791 $2,982 $24,988 $17,549
End Cash Position $170,572 $176,229,874 $86,204,394 $9,192,703
Beginning Cash Position $176,229,874 $86,204,394 $9,192,703 $21,925,322
Effect Of Exchange Rate Changes $-153,483 $-1,123,015 $-1,272,164 $-436,513
Changes In Cash $-175,905,819 $91,148,495 $78,283,855 $-12,296,106
Net Issuance Payments Of Debt $350,000 $0 $-7,686,152 $-27,513,848
Net Short Term Debt Issuance $350,000 $0 $-7,686,152 $-27,513,848
Short Term Debt Payments $0 $0 $-7,686,152 $-27,513,848
Short Term Debt Issuance $350,000 $0 $0 -
Net Business Purchase And Sale $0 $-93,750,000 $-56,250,000 $0
Purchase Of Business $0 $-93,750,000 $-56,250,000 $0
Net Intangibles Purchase And Sale $-175,664,545 $0 $0 -
Purchase Of Intangibles $-175,664,545 $0 $0 -
Net PPE Purchase And Sale $-1,638 $-154,460 $0 $0
Purchase Of PPE $-1,638 $-154,460 $0 $0
Change In Working Capital $-11,349,701 $3,018,202 $2,056,439 $-1,173,070
Change In Other Working Capital $-5,809,914 $9,859,227 $220,644 $194,376
Change In Other Current Liabilities $-56,605 $82,195 $0 $0
Change In Payables And Accrued Expense $372,939 $376,636 $144,131 $716,075
Change In Accrued Expense $527 $0 $0 -
Change In Interest Payable $527 $0 $0 -
Change In Payable $372,412 $376,636 $144,131 $716,075
Change In Account Payable $312,991 $417,184 $166,045 $712,885
Change In Tax Payable $59,421 $-40,548 $-21,914 $3,190
Change In Income Tax Payable $59,421 $-40,548 $-21,914 $3,190
Change In Prepaid Assets $-5,420,639 $-6,440,314 $-130,770 $-95,151
Change In Inventory $0 $0 $1,495,248 $6,109,372
Change In Receivables $-435,482 $-859,542 $327,186 $-8,097,742
Changes In Account Receivables $-435,482 $-859,542 $327,186 $-8,097,742
Other Non Cash Items $84,129 $-98,947 $395,914 -
Provisionand Write Offof Assets $108,617 $-100,000 $7,369,797 $8,274,526
Asset Impairment Charge $16,700,276 $162,481,379 $0 $0
Deferred Tax $-1,990,055 $-30,804,128 $0 $0
Deferred Income Tax $-1,990,055 $-30,804,128 $0 $0
Depreciation Amortization Depletion $2,371,615 $2,149,790 $0 $0
Depreciation And Amortization $2,371,615 $2,149,790 $0 $0
Net Income From Continuing Operations $-18,716,181 $-135,469,133 $-9,116,779 $-13,084,038
Depreciation - $2,149,790 $0 $0
Stock Based Compensation - - $0 $0
Proceeds From Stock Option Exercised - - - $0
Common Stock Payments - - - -
Net Long Term Debt Issuance - - - -
Long Term Debt Payments - - - -
Net Investment Purchase And Sale - - - -
Purchase Of Investment - - - -
Sale Of PPE - - - -
Interest Paid Cfo - - - -
Change In Other Current Assets - - - -
Gain Loss On Sale Of PPE - - - -
Long Term Debt Issuance - - - -
Fetched: 2026-10-27